Brevan Howard Capital Management LP Ptc Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 12,197 shares of PTCT stock, worth $616,802. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,197Holding current value
$616,802% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
257Shares Held
77.3MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$464 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$393 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$374 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$323 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$242 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.62B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...